Work

Post Transplant Outcome of a Multicenter Phase II Study of Brentuximab Vedotin As First Line Salvage Therapy in Relapsed/Refractory HL Prior to AHCT

Year: 2015

Type: article

Source: Blood

DOI: 10.1182/blood.v126.23.519.519

Authors: Robert Chen, Joycelynne Palmer, Peter Martin, Saro Armenian, Nichun Tsai, Michelle Mott, Firoozeh Sahebi, Ji-Lian Cai, Tanya Siddiqi, Leslie L. Popplewell, John P. Leonard, Auayporn P. Nademanee, Steven T. Rosen, Larry W. Kwak, Stephen J. Forman

Institutions: City Of Hope National Medical Center, City of Hope, Weill Cornell Medicine, Kaiser Permanente, Beckman Research Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2586677173

FWCI: 2.074

Cites:

Cited by: 13

Related to: 10